Skip to main content
. 2014 Jun 19;111(2):241–248. doi: 10.1038/bjc.2014.346

Table 2. Efficacy outcomes.

Outcomes BECOX population (n=68)
Time to progression, months
Median (95% CI)
11.1 (8.1–14.1)
Overall survival, months
Median (95% CI)
20.4 (13.2–27.6)
Best response, n (%)
Complete 2 (3)
Partial 29 (43)
Stable disease 23 (34)
Progressive disease 14 (21)
Overall response rate, % (95% CI) 45.6 (33.6–58.1)
Disease-control rate, % (95% CI)
79.4 (67.6–87.9)
Confirmed response, n (%)
Complete 2 (3)
Partial 21 (31)
Stable disease 31 (46)
Progressive disease 2 (3)
Overall response rate, % (95% CI) 33.8 (23.1–46.4)
Disease-control rate, % (95% CI) 79.4 (67.6–87.9)

Abbreviation: CI=confidence interval.